Axsome Therapeutics Inc.
AXSM | NASDAQ
$205.34
-$2.44 (-1.17%)
Sep 21, 2026, 12:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 638.5M | 385.69M | 270.6M | 50.04M | n/a | n/a |
Cost of Revenue | 47.48M | 33.3M | 26.07M | 5.2M | n/a | n/a |
Gross Profit | 591.02M | 352.39M | 244.54M | 44.84M | n/a | n/a |
Operating Income | -169.24M | -280.56M | -231.83M | -179.8M | -124.71M | -99.14M |
Interest Income | 9.37M | n/a | n/a | n/a | n/a | 2.57M |
Pretax Income | -183.7M | -287.13M | -238.28M | -187.13M | -130.4M | -102.9M |
Net Income | -183.17M | -287.22M | -239.24M | -187.13M | -130.4M | -102.9M |
Selling & General & Admin | 570.6M | 411.36M | 323.12M | 159.25M | 66.65M | 28.9M |
Research & Development | 183.28M | 187.08M | 97.94M | 57.95M | 58.06M | 70.24M |
Other Expenses | 6.38M | 34.52M | 55.29M | 7.44M | n/a | -53.58K |
Operating Expenses | 760.25M | 632.95M | 476.36M | 224.64M | 124.71M | 99.14M |
Interest Expense | 6.56M | 6.57M | 6.45M | 7.34M | 5.7M | 2.57M |
Selling & Marketing Expenses | n/a | 101.2M | 100.3M | n/a | -205 | n/a |
Cost & Expenses | 807.73M | 666.26M | 502.43M | 229.84M | 124.71M | 99.09M |
Income Tax Expense | -530K | 85K | 960K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 49.75M | 47.91M | 45.43M | 40.66M | 37.62M | 37.21M |
Shares Outstanding (Diluted) | 49.75M | 47.91M | 45.43M | 40.66M | 37.62M | 37.21M |
EPS (Basic) | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | -2.83 |
EPS (Diluted) | -3.68 | -5.99 | -5.27 | -4.60 | -3.47 | -2.83 |
EBITDA | -168.08M | -272.6M | -224.99M | -175.4M | -124.63M | -100.31M |
EBIT | -177.15M | -280.56M | -231.83M | -179.8M | -124.71M | -100.39M |
Depreciation & Amortization | 9.06M | 7.96M | 6.83M | 4.4M | 76K | 77.72K |
Add to Watchlist
Select watchlists to add or remove AXSM